Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial

Fig 1

Number of individuals screened, randomized and allocated to the three vaccination groups and withdrawn from the trial.

Fig 1

doi: https://doi.org/10.1371/journal.pone.0119629.g001